Heartseed

  • NEWS
  • PIPELINE
  • TECHNOLOGY
  • ABOUT US
    • CEO Message
    • Purpose
    • Company Profile
    • Management
  • Mission & Values
  • IR
    • IR News
    • Management
    • IR Library
    • Stock Information
    • Other Contents
  • CONTACT
  • JP/EN
  1. HOME
  2. NEWS
  3. Media

Media

20241114

Media CEO Keiichi Fukuda Interviewed by BiotechTV

2024108

Media Heartseed was featured on CNN's "Tomorrow Transformed".

202493

Media An article by COO Kikuo Yasui on Japan's drug discovery ecosystem has been published in "BioSpectrum Asia".

202482

Media Heartseed was Featured on NHK World's "jib TV"

2024227

Media Heartseed was selected as the Japan's ten hottest biotech companies in healthcare by LABIOTECH

2023613

Media Heartseed selected as "Six companies that have made their name in the cardiovascular space" by LABIOTECH

2023319

Media News article about the initiation of a clinical trial of Heartseed was published in Nature Medicine.

2022620

Media Interview with Keiichi Fukuda was published in "Features", Keio University School of Medicine.

202267

Media Interview with Takehiko Kaneko, CMO and Head of R&D at Heartseed, was published in RegMedNet.

2022128

Media Heartseed was featured by NHK World's CATCH JAPAN.

1 2

COMPANY OVERVIEW

To transform treatment of severe heart failure by delivering cardiac regenerative medicine, Heartseed Inc. was founded in 2015. It has also been developing technologies to expand the access of RM.

Company name
Heartseed Inc.
Head Office
Seavans South Building 5F, 1-2-3 Shibaura, Minato-ku, Tokyo 105-0023, JAPAN
Contact
contact@heartseed.jp

MORE VIEW

MENU

  • Home
  • News
  • PIPELINE
  • TECHNOLOGY
  • About us
  • Mission & Values
  • IR
  • Contacts

language

  • English
  • Japanese

GO TO TOP

Copyright © All Rights Reserved HEARTSEED HEARTSEED